Gerresheimer (GRRMF) Expected to Announce Earnings on Wednesday

Gerresheimer (OTCMKTS:GRRMF) is expected to announce its results before the market opens on Wednesday, November 4th. Analysts expect the company to post earnings of $0.3166 per share and revenue of $671.32 million for the quarter.

Gerresheimer Stock Performance

Shares of GRRMF stock opened at $37.47 on Tuesday. The stock’s 50-day moving average price is $31.88 and its 200 day moving average price is $29.61. Gerresheimer has a 52-week low of $19.16 and a 52-week high of $37.47.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on GRRMF shares. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Gerresheimer in a research note on Tuesday, August 4th. UBS Group upgraded Gerresheimer from a “sell” rating to a “neutral” rating in a research note on Tuesday, August 4th. Four analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Reduce”.

Gerresheimer Company Profile

Gerresheimer AG is a Germany-based manufacturer of pharmaceutical and healthcare packaging and drug-delivery systems. The company develops and produces primary packaging and components used to protect, store and administer medicines, serving pharmaceutical, biotechnology and healthcare customers worldwide.

Its product portfolio includes glass and plastic containers such as vials, ampoules, bottles, cartridges and syringes, as well as delivery systems including inhalers, injection pens, autoinjectors and other medical devices.